Comparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis
Open Access
- 1 January 2015
- journal article
- research article
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 141 (4), 463-8
- https://doi.org/10.4103/0971-5916.159297
Abstract
Background & objectives: Tuberculosis (TB) is a common infection in patients on haemodialysis. There is a definite role of treatment of latent TB (LTB) in these patients. However, diagnosis of LTB in these patients by tuberculin skin test (TST) is unreliable. There is suggestion that interferon gamma release assay (IGRA) will be more reliable test for diagnosis of LTB in this setting. Thus, we evaluated value of IGRA and TST for the diagnosis of LTB in patients on dialysis in an Indian setting. Methods: Patients with end stage kidney disease on dialysis were included. Patients with active TB were excluded. Each patient was subjected to TST (induration of ≥10 mm was taken as positive) and QuantiFERON TB Gold In-Tube test (QFT-GIT) for diagnosis of LTB. Results: A total of 185 patients were included; 129 (69.7%) were males and mean age was 36.7 ± 12.3 yr. Past history of TB was present in 18 (9.7%) patients. One hundred and thirty four (72.4%) patients had scar of BCG vaccination. QFT-GIT test was positive in 66 (36%), TST in 32 (17%) and both in 13 (7%) patients. Of the 66 patients positive with QFT-GIT, only 13 (19.6%) were positive for TST. Of the 32 patients positive with TST, only 13 (40.6%) were positive with QFT-GIT; 100 (54%) patients were negative for both the tests. Overall, 85 (45.9%) patients were positive for either of the two tests. Poor agreement was shown between the two methods. On logistic regression analysis, odds of QFT-GIT to be positive in patients with BCG vaccination was 1.23 and with history of TB 0.99, both being insignificant. odds of tuberculin skin test to be positive in patients with BCG vaccination was 1.04 and with history of TB 0.99, both again being insignificant. Interpretation & conclusions: Our findings showed that more number of patients (36%) on haemodialysis were positive for QuantiFERON Gold In-Tube test as compared to TST (17%). There was poor agreement between the two tests. No significant effect of BCG vaccination and history of TB in past was observed on both tests.Keywords
This publication has 28 references indexed in Scilit:
- Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosisBMC Infectious Diseases, 2012
- QuantiFERON-TB Gold test for screening latent tuberculosis infection in hemodialysis patients.2011
- Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney diseaseThorax, 2010
- Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantationTransplant Infectious Disease, 2010
- Tuberculin skin test for the diagnosis of latent tuberculosis during renal replacement therapy in an endemic area: A single center studyIndian Journal of Nephrology, 2010
- Detecting Latent Tuberculosis Infection in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2007
- Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patientsKidney International, 2004
- The Tuberculin Skin TestClinical Infectious Diseases, 1993
- Mycobacteriosis in Patients With Chronic Renal FailureArchives of Internal Medicine, 1980
- T-Lymphocytes and Serum Inhibitors of Cell-Mediated Immunity in Renal InsufficiencyNephron, 1975